ACET – adicet bio, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ACET

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/19

06:02 am

acet

Adicet Bio (NASDAQ:ACET) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..

Medium Report

Adicet Bio (NASDAQ:ACET) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..

Report

11/6

01:21 pm

acet

Adicet Bio (NASDAQ:ACET) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.

Low Report

Adicet Bio (NASDAQ:ACET) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.

Report

11/6

01:21 pm

acet

Adicet Bio (NASDAQ:ACET) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.

Low Report

Adicet Bio (NASDAQ:ACET) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.

Report

10/8

08:27 am

acet

Rating for ACET

Medium Report

Rating for ACET

Report

10/8

08:27 am

acet

Rating for ACET

Medium Report

Rating for ACET

Report

10/8

08:20 am

acet

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim.

Medium Report

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

10/8

08:20 am

acet

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim.

Medium Report

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

9/19

08:47 am

acet

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $7.00 price target on the stock.

Medium Report

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $7.00 price target on the stock.

Report

9/19

08:47 am

acet

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $7.00 price target on the stock.

Medium Report

Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $7.00 price target on the stock.

Report

9/19

08:44 am

acet

Rating for ACET

Medium Report

Rating for ACET

Report

9/19

08:44 am

acet

Rating for ACET

Medium Report

Rating for ACET

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.